Nuclear energy's role in reducing carbon emissions and high efficiency makes it a significant player in the clean energy ...

Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...

AstraZenca is testing a once-daily PCSK9 inhibitor, currently known as AZD0780. After 12 weeks of use alongside standard ...

AstraZeneca Pharmaceuticals LP and a Christian sales specialist have agreed to settle his suit over the company’s failure to ...

AstraZeneca PLC closed 27.79% below its 52-week high of £133.88, which the company achieved on September 3rd.

Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p15,318.00.

With its ability to specifically inhibit the mutant IDH1 enzyme, TIBSOVO addresses an unmet need in personalized cancer treatment, offering new hope for patients with limited options. As clinical ...

SBA loans are small-business loans offered by banks and online lenders and partly guaranteed by the government. Check SBA loan rates for 2025SBA loans offer some of the lowest rates on the market ...

One bright spot for Chancellor Rachel Reeves is the fact the British economy is 75% services – left untouched by the tariffs ...